170330 ONJCRI 0392

Involvement in clinical trials

Through the trial of new treatments we give hope to patients today and into the future.

The Olivia Newton-John Cancer Research Institute is embedded within a hospital to be able to offer clinical trials of new breakthrough treatments to patients with cancer. 

At any one time, our scientists are involved in up to 60 ongoing clinical trials. Trials are in progress for a variety of cancer types including brain, bowel, breast, melanoma, gastrointestinal, head and neck, pancreatic, prostate and lung cancer.



Medicinal cannabis clinical trial

The Olivia Newton-John Cancer Research Institute will soon lead a randomised phase I/II clinical trial to evaluate the use of medicinal cannabis for patients with advanced cancer.


The objective of this trial is to assess the impact medicinal cannabis has on the quality of life of trial participants in the palliative care setting. This will be a first-of-its-kind clinical trial in Victoria and one of only a few being conducted world-wide. This project is being partially funded by the Victorian Government.


Throughout the trial, participants will be monitored closely for improvements in global quality of life, pain, appetite, anxiety, nausea, fatigue, sleep and weight loss. Further funding is sought to identify whether the use of cannabis may have any anti-cancer activity.


108 trial participants will be recruited from four National hospitals. This trial will not be made available to the public but rather participants will be invited by their oncologist/oncology team if they meet all pre-determined selection criteria.

Experience in clinical trials

The scientists, clinicians and research colleagues of the Olivia Newton-John Cancer Research Institute have been investigators on 180 clinical trials spanning "First time in human" investigations, through to multinational phase III trials.

Helping future generations

More than 1000 Austin Health patients have participated in these trials conducted by the Olivia Newton-John Cancer Research Institute, furthering the field's understanding of how to detect and treat cancers of various origins.

Do you want to join a clinical trial?

Learn more